Fexofenadine Hydrochloride / Pseudoephedrine Hydrochloride
Pronouncation: (fex-oh-FEN-ah-deen HIGH-droe-KLOR-ide/SUE-doe-eh-FED-rin)Class: Antihistamine, Decongestant
Trade Names:
Allegra-D
- Tablets 120 mg pseudoephedrine/60 mg fexofenadine
Pharmacology
Competitively antagonizes histamine at the H 1 -receptor site.
PseudoephedrineCauses vasoconstriction and subsequent shrinkage of nasal mucous membranes by alpha-adrenergic stimulation, promoting nasal drainage.
Indications and Usage
Relief of symptoms associated with seasonal allergic rhinitis.
Contraindications
Hypersensitivity to any ingredient of the product; patients with narrow-angle glaucoma, urinary retention, severe hypertension, or severe coronary artery disease; MAOI therapy; idiosyncratic reactions to adrenergic agents.
Dosage and Administration
Adults and Children 12 yr of age and olderPO 1 tablet (60 mg fexofenadine/120 mg pseudoephedrine) twice daily.
General Advice
- Give on an empty stomach, 1 h before or 2 h after eating.
Storage/Stability
Store tablets at controlled room temperature. Keep container tightly closed.
Drug Interactions
Because the following interactions may occur with the components of this product, take these interactions into consideration when administering the agents that are listed.
Fexofenadine Erythromycin, ketoconazolePlasma levels of fexofenadine may be increased.
Pseudoephedrine MAOIsContraindicated in patients taking MAOIs and for 14 days after stopping use of an MAOI.
Antihypertensive agents that interfere with sympathetic activity (eg, mecamylamine, methyldopa, reserpine, veratrum alkaloids)Antihypertensive effect of these agents may be reduced.
DigitalisIncreased ectopic pacemaker activity may occur.
Laboratory Test Interactions
May diminish or prevent positive reactions to skin tests.
Adverse Reactions
Cardiovascular
Palpitations; tachycardia, pressor activity, cardiac arrhythmias, CV collapse (pseudoephedrine).
CNS
Headache; insomnia; dizziness; agitation; nervousness; anxiety; excitability, restlessness, weakness, drowsiness, fear, tenseness, hallucinations, seizures (pseudoephedrine).
Dermatologic
Pallor.
EENT
Throat irritation.
GI
Nausea; dry mouth; dyspepsia; abdominal pain.
Genitourinary
Dysuria.
Respiratory
Upper respiratory infection; respiratory difficulties.
Miscellaneous
Back pain.
Precautions
MonitorAssess for allergy symptoms before and periodically throughout therapy. Monitor pulse and BP periodically during therapy. |
Pregnancy
Category C .
Lactation
FexofenadineUndetermined.
PseudoephedrineExcreted in breast milk.
Children
Safety and efficacy not established in children younger than 12 yr of age.
Elderly
Use lower starting dose, reflecting increased incidence of adverse reactions due to decreased hepatic, renal, or cardiac function and comorbidity.
Special Risk Patients
Use with caution in patients with hyperthyroidism, severe hypertension, diabetes, CV disease, increased IOP, or prostatic hypertrophy.
Sympathomimetic amines (eg, pseudoephedrine)
May cause CNS stimulation with convulsions or CV collapse with accompanying hypotension. Monitor patient for nervousness, dizziness, and insomnia.
Overdosage
Symptoms
Dizziness, drowsiness, dry mouth, giddiness, headache, nausea, vomiting, sweating, thirst, tachycardia, precordial pain, palpitations, difficulty in micturition, muscular weakness and tension, anxiety, restlessness, insomnia, toxic psychosis with delusions and hallucinations, cardiac arrhythmias, circulatory collapse, convulsions, coma, respiratory failure.
Patient Information
- Advise patient to take twice daily as prescribed, on an empty stomach, 1 h before or 2 h after eating.
- Advise patient to take last dose late in afternoon or early evening to reduce chance of drug causing sleeplessness.
- Caution patient not to break, chew, or crush tablet and to swallow whole.
- Advise patient that if allergy symptoms are not controlled, not to increase the dose of medication but to inform the health care provider.
- Do not take this medication more than 4 days before having allergy skin test.
- Instruct patient to stop taking the drug and immediately report any of the following symptoms to health care provider: nervousness, dizziness, or sleeplessness.
| Link to this page |  |
Printable Version |  |
Email Page |  |
Add to my drug list |
User Reviews:
4 comment(s) about Fexofenadine Hydrochloride/Pseudoephedrine Hydrochloride
